IP Library › Granted Patent US 11,672,861
Granted Patent B2
US 11,672,861 · App. 16/358,468 · Granted Jun 13, 2023

Prussian blue nanoparticles functionalized with immune signals and applications thereof

Inventors: Rohan Fernandes (Bethesda, MD); Elizabeth Sweeney (Washington, DC); Juliana Cano-Mejia (Arlington, VA)
Assignee: The George Washington University
A61K41/0052A61B5/0071A61B5/055A61B6/481A61B8/481A61K9/5052A61K9/51A61K31/7088A61K33/26A61K38/19A61N5/062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,861
App. No.
16/358,468
Granted
Jun 13, 2023
Kind
B2
Abstract

Biofunctionalized nanocomposites comprised of a core nanoparticle formed of Prussian blue materials, a shell obtained by partially or completely encapsulating the Prussian blue core with a biocompatible coating, and at least one biomolecule attached to, or absorbed to, the biocompatible coating and uses thereof.

Claims (20)

1. A biofunctionalized nanocomposite, comprising:

(a) a core comprising Prussian blue materials;

(b) a positively charged biocompatible coating comprising polyethylenimine (PEI) having an average molecular weight (MW) of about 2000 daltons; and

at least one CpG oligodeoxynucleotide attached to the outer surface of the positively charged biocompatible coating.

2. The biofunctionalized nanocomposite of claim 1 , wherein the Prussian blue materials are iron hexacyanoferrate (II) compounds.

3. The biofunctionalized nanocomposite of claim 1 , wherein the Prussian blue materials are represented by general formula (I):

A x B y M 4 [M′(CN) 6 ] z ·n H 2 O  (I)

wherein:

A represents at least one of VO 2 , Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Sr, Zr, Nb, Li, Na, K, Rb, Cs, Fr, Tl, Mo, Ru, Rh, Pd, Ag, Cd, In, Lu, Ba, Hf, Ta, W, Os, Pt, Hg, La, Eu, Gd, Tb, Dy and Ho, in any oxidation state and any combination thereof;

B represents at least one of VO 2 , Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Sr, Zr, Nb, Li, Na, K, Rb, Cs, Fr, Tl, Mo, Ru, Rh, Pd, Ag, Cd, In, Lu, Ba, Hf, Ta, W, Os, Pt, Hg, La, Eu, Gd, Tb, Dy and Ho, in any oxidation state and any combination thereof;

M represents at least one of VO 2 , Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Sr, Zr, Nb, Li, Na, K, Rb, Cs, Fr, Tl, Mo, Ru, Rh, Pd, Ag, Cd, In, Lu, Ba, Hf, Ta, W, Os, Pt, Hg, La, Eu, Gd, Tb, Dy and Ho, in any oxidation state and any combination thereof;

M′ represents at least one of VO 2 , Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Sr, Zr, Nb, Li, Na, K, Rb, Cs, Fr, Tl, Mo, Ru, Rh, Pd, Ag, Cd, In, Lu, Ba, Hf, Ta, W, Os, Pt, Hg, La, Eu, Gd, Tb, Dy and Ho, in any oxidation state and any combination thereof;

x is from 0.1 to about 1;

y is from 0.1 to about 1;

z is from 0.1 to about 4; and

n is from 0.1 to about 24.

4. The biofunctionalized nanocomposite of claim 1 , wherein at least 75% of the outer surface of the positively charged biocompatible coating has a CpG oligodeoxynucleotide attached thereto.

5. The biofunctionalized nanocomposite of claim 1 , wherein the average molecular weight of the PEI is 2000 Daltons.

6. The biofunctionalized nanocomposite of claim 1 , wherein the biofunctionalized nanocomposite is a photothermal therapy agent.

7. The biofunctionalized nanocomposite of claim 6 , wherein the positively charged biocompatible coating further comprises an imaging agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2019
From: FERNANDES, ROHAN; CANO-MEJIA, JULIANA; SWEENEY, ELIZABETH
To: THE GEORGE WASHINGTON UNIVERSITY
Reel/Frame 048886/0383 →
Continuity (2)
Provisional Application 62745843 · Oct 15, 2018
Related Publication 20200114005A1 · Apr 16, 2020